Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted versus empiric antibiotic prophylaxis for infection prevention after transrectal prostate biopsy
ACTRN12622000149763Phase 4Completed
- Sponsor
- Sotirios Gatsos
- Start
- Aug 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofloxacin in urinary tract infection (UTI) and prostatitis (2 arms), sponsored by Sotirios Gatsos. Primary endpoint: Difference in infectious complication rates after transrectal ultrasound-guided prostate biopsy. Started Aug 2019; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
urinary tract infection (UTI)prostatitis
Beyond the preview
Go deeper on ACTRN12622000149763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000149763.